ResearcherSheng Jing HospitalActive in the last 2 years

Xiaodong Tan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0008-8431-1493; OpenAlex author ID A5125669435. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 3

Papers, trials and grants by year

2026: 2 papers

Papers 2

OTUD4 regulates pancreatic cancer progression via Hippo/YAP axis. Last author DOI 10.1016/j.neo.2026.101285 ↗
Radiopathomics Signature for Prognosis and Prediction of Chemotherapy Benefit in Unresectable Pancreatic Cancer. Last author DOI 10.1200/po-25-00581 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xinkang Hu · 1 shared paper, 2026 · strength 0.36
- Paper Radiopathomics Signature for Prognosis and Prediction of Chemotherapy Benefit in Unresectable Pancreatic Cancer. DOI 10.1200/po-25-00581 ↗
Jian Zhu · 1 shared paper, 2026 · strength 0.27
- Paper OTUD4 regulates pancreatic cancer progression via Hippo/YAP axis. DOI 10.1016/j.neo.2026.101285 ↗
Shuaike Qu · 1 shared paper, 2026 · strength 0.27
- Paper OTUD4 regulates pancreatic cancer progression via Hippo/YAP axis. DOI 10.1016/j.neo.2026.101285 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.